Evidence map›Paper›PMID 18280813›Full record

ArticleBiochimica et biophysica acta2008

Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.

Teresa Golden, Ileana V Aragon, Beth Rutland, J Allan Tucker, Lalita A Shevde, Rajeev S Samant, Guofei Zhou, Lauren Amable, Danalea Skarra, Richard E Honkanen

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Teresa GoldenDepartment of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL 36688, USA.
Ileana V Aragon
Beth Rutland
J Allan Tucker
Lalita A Shevde
Rajeev S Samant
Guofei Zhou
Lauren Amable
Danalea Skarra
Richard E Honkanen
University of South Alabama · USUSA Mitchell Cancer Institute · USKarolinska Institutet · SE

Funding

The Impact of Family Labor Market Status on Access to Health CareP20MD002314 · NIMHD · UNIVERSITY OF SOUTH ALABAMA · PI GERTHOFFER, WILLIAM T · 2007 to 2016
$12.9M
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESISR01CA060750 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 1999 to 2009
$2.5M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR011174 · NCRR · UNIVERSITY OF SOUTH ALABAMA · PI ABEE, CHRISTIAN R · 1995 to 1995
–
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESISR29CA060750 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 1994 to 1998
–
NCI NIH HHS CA-60750NCI NIH HHS R01 CA060750NCRR NIH HHS C06 RR11174NIMHD NIH HHS P20 MD-002314NIMHD NIH HHS P20 MD002314
6 · The paper itself

Abstract

Ser/Thr protein phosphatase 5 (PP5) regulates several signaling-cascades that suppress growth and/or facilitate apoptosis in response to genomic stress. The expression of PP5 is responsive to hypoxia inducible factor-1 (HIF-1) and estrogen, which have both been linked to the progression of human breast cancer. Still, it is not clear if PP5 plays a role in the development of human cancer. Here, immunostaining of breast cancer tissue-microarrays (TMAs) revealed a positive correlation between PP5 over-expression and ductal carcinoma in situ (DCIS; P value 0.0028), invasive ductal carcinoma (IDC; P value 0.012) and IDC with metastases at the time of diagnosis (P value 0.0001). In a mouse xenograft model, the constitutive over-expression of PP5 was associated with an increase in the rate of tumor growth. In a MCF-7 cell culture model over-expression correlated with both an increase in the rate of proliferation and protection from cell death induced by oxidative stress, UVC-irradiation, adriamycin, and vinblastine. PP5 over-expression had no apparent effect on the sensitivity of MCF-7 cells to taxol or rapamycin. Western analysis of extracts from cells over-expressing PP5 revealed a decrease in the phosphorylation of known substrates for PP5. Together, these studies indicate that elevated levels of PP5 protein occur in human breast cancer and suggest that PP5 over-expression may aid tumor progression.

Indexed as

AnimalsBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingCell DeathCell Line, TumorDoxorubicinHumansMiceMice, NudeNuclear ProteinsOxidative StressPhosphoprotein PhosphatasesThreonineTime FactorsUltraviolet RaysDoxorubicinNuclear ProteinsPhosphoprotein Phosphatasesprotein phosphatase 5ThreonineVinblastine

Identifiers

PMID18280813
PMCPMC2505351
OpenAlexW2117581689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.